New research suggests that short-term online mindfulness programs can ease depression, especially when they help people become less reactive to distressing thoughts. Longer-term benefits were more likely when mindfulness was combined with cognitive techniques.
Despite affecting thousands under 65, young-onset dementia is frequently misdiagnosed or overlooked. This article outlines five key reasons why the condition remains under-recognized—and why better awareness is essential for early support and care.
A new study suggests long-term SSRI use may reduce markers of Alzheimer’s disease and restore brain function in affected regions, but the impact on cognitive performance remains mixed depending on how it’s measured.
A large-scale analysis of spinal fluid has identified distinct protein patterns that may allow for earlier diagnosis and monitoring of frontotemporal dementia, a midlife-onset brain disorder often misdiagnosed due to its wide-ranging symptoms and lack of biomarkers.
Hot flashes and brain fog during menopause may be warning signs of more than just hormonal changes. A new study links the number of menopause symptoms to future risks of cognitive decline and behavioral changes tied to dementia.
In a study using an Alzheimer’s disease mouse model, researchers found that cannabidiol reduced memory loss and brain abnormalities. The compound worked by enhancing the function of glycine receptors, which help regulate neuronal activity in the brain's memory center.
A virus best known for causing cold sores may dramatically increase the risk of Alzheimer’s in people with a specific gene variant. New evidence suggests herpes reactivation in the brain may trigger the destructive changes seen in the disease.
A large study tracking older adults over a decade found that higher psychological well-being predicts better cognitive health—and vice versa. The strongest effects were seen for people with a strong sense of purpose.
New research involving over 411,000 adults finds that greater use of technology, such as computers and smartphones, is linked to reduced cognitive decline in later life—offering a hopeful counterpoint to the “digital dementia” narrative.
Dispositional mindfulness is lower in people with mild cognitive impairment compared to those with subjective concerns, and brain imaging points to emotion-related connectivity differences that may reflect early neurodegenerative processes.
A groundbreaking genome-wide analysis has revealed new genetic regions associated with Alzheimer’s disease—many missed in past studies focused on European populations. The findings point to underexplored biological pathways and highlight the value of studying diverse ancestry groups.
A low-cost, noninvasive eye scan could help detect Alzheimer’s disease earlier than current methods. The technique may expand access to early diagnosis, especially in underserved communities, and provide a valuable tool for intervention before irreversible brain damage occurs.
Scientists have discovered that increasing levels of a protein called Hevin in the brain reverses memory loss in aging and Alzheimer’s model mice. The findings suggest a new way to improve cognition without targeting amyloid plaques.
A brain scan study comparing dementia patients to healthy individuals reveals how frontotemporal dementia impairs emotional empathy. The findings could help scientists understand the disease’s early progression and eventually guide development of targeted interventions.
A recent review published in Cureus explores the relationship between caffeine and Alzheimer’s disease. The findings suggest that higher caffeine intake may reduce the risk of cognitive decline, especially in people with early symptoms of memory impairment.